Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CAPRICOR THERAPEUTICS, INC. | CHIEF FINANCIAL OFFICER | Common Stock | 2.38K | $3.31K | $1.39 | Oct 23, 2023 | Direct |
CAPRICOR THERAPEUTICS, INC. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 9.69K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | CHIEF FINANCIAL OFFICER |
CAPR | CAPRICOR THERAPEUTICS, INC. | Oct 23, 2023 | 2 | $3.03K | 4 | Oct 24, 2023 | CHIEF FINANCIAL OFFICER |
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | CHIEF FINANCIAL OFFICER |
CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | CHIEF FINANCIAL OFFICER |